Literature DB >> 1602142

HLA-J, a second inactivated class I HLA gene related to HLA-G and HLA-A. Implications for the evolution of the HLA-A-related genes.

G Messer1, J Zemmour, H T Orr, P Parham, E H Weiss, J Girdlestone.   

Abstract

Ragoussis and co-workers (Genomics 4:301) previously described a class I HLA gene (now designated HLA-J) that maps to within 50 kb of HLA-A. The nucleotide sequences of three HLA-J alleles are reported here. Comparison of the nucleotide sequences of HLA-J alleles shows this gene is more related to HLA-G, A, and H than to HLA-B, C, E, and F. All four alleles of HLA-J are pseudogenes because of deleterious mutations that produce translation termination either in exon 2 or exon 4. Apart from these mutations, the predicted proteins have structures similar to those of HLA-A, B, and C molecules. There is, however, little polymorphism at HLA-J and none at functional positions of the Ag-recognition site. The polymorphism is less than found for HLA-H another HLA-A-related pseudogene. HLA-J appears, like HLA-H, to be an inactivated gene that result from duplication of an Ag-presenting locus related to HLA-A. Nucleotide sequence comparisons show that the HLA-A, H, J, and G genes form a well defined group of "HLA-A-related" loci. Evolutionary relationships as assessed by construction of trees suggest the four modern loci: HLA-A, G, H, and J were formed by successive duplications from a common ancestral gene. In this scheme one intermediate locus gave rise to HLA-A and H, the other to HLA-G and J.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Nomenclature for factors of the HLA system, 2010.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; M Fernández-Viña; D E Geraghty; R Holdsworth; C K Hurley; M Lau; K W Lee; B Mach; M Maiers; W R Mayr; C R Müller; P Parham; E W Petersdorf; T Sasazuki; J L Strominger; A Svejgaard; P I Terasaki; J M Tiercy; J Trowsdale
Journal:  Tissue Antigens       Date:  2010-04

2.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.

Authors:  Michael Gleimer; Angela R Wahl; Heather D Hickman; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; John A Hammond; Monia Draghi; Erin J Adams; Sean Juo; Roxana Jalili; Baback Gharizadeh; Mostafa Ronaghi; K Christopher Garcia; William H Hildebrand; Peter Parham
Journal:  J Immunol       Date:  2011-01-05       Impact factor: 5.422

4.  Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors.

Authors:  J Girdlestone; M Isamat; D Gewert; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Stem-loop potential in MHC genes: a new way of evaluating positive Darwinian selection?

Authors:  D R Forsdyke
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  Epigenome-wide association study and network analysis for IgA Nephropathy from CD19+ B-cell in Chinese Population.

Authors:  Yifei Lin; Peiran Yin; Zhaozhong Zhu; Yuan Peng; Ming Li; Jun Li; Liming Liang; Xueqing Yu
Journal:  Epigenetics       Date:  2021-01-07       Impact factor: 4.528

7.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Authors:  J Zemmour; P Parham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

8.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

9.  HLA-H: Transcriptional Activity and HLA-E Mobilization.

Authors:  François Jordier; Delphine Gras; Maria De Grandis; Xavier-Benoît D'Journo; Pascal-Alexandre Thomas; Pascal Chanez; Christophe Picard; Jacques Chiaroni; Julien Paganini; Julie Di Cristofaro
Journal:  Front Immunol       Date:  2020-01-17       Impact factor: 7.561

10.  HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer.

Authors:  Franziska M Würfel; Ralph M Wirtz; Christoph Winterhalter; Mario Taffurelli; Donatella Santini; Anna Mandrioli; Elke Veltrup; Matthias Rübner; Peter A Fasching; Wolfgang Würfel; Claudio Zamagni
Journal:  Geburtshilfe Frauenheilkd       Date:  2020-11-06       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.